88 related articles for article (PubMed ID: 1694981)
1. Multifocal extranodal lymphomas: an expression of homing phenomenon.
Advani SH; Iyer RS; Gopal R; Nair CN; Saikia T; Dinshaw KA; Kurkure PA; Pai SK
Oncology; 1990; 47(4):334-8. PubMed ID: 1694981
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of malignant lymphoma with extranodal lesions--current trends and new strategies in chemotherapy].
Okumura H
Rinsho Ketsueki; 1999 Mar; 40(3):196-8. PubMed ID: 10222625
[No Abstract] [Full Text] [Related]
3. [Chemotherapy of malignant lymphomas].
Luporini G
Radiol Med; 1976; 62(7-8):553-7. PubMed ID: 95671
[TBL] [Abstract][Full Text] [Related]
4. Results of the cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) +/- bleomycin treatment and evaluation of prognostic factors in aggressive lymphomas in Turkey.
Dinçol D; Akbulut H; Içli F; Samur M; Karaoğuz H; Demirkazik A; Cay F
Oncology; 1997; 54(5):376-9. PubMed ID: 9260598
[TBL] [Abstract][Full Text] [Related]
5. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
Konopka L; Pawelski S
J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
[No Abstract] [Full Text] [Related]
6. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
[TBL] [Abstract][Full Text] [Related]
7. [Modified CHOP-Bleo protocol in the treatment of malignant non-Hodgkin's lymphoma of low cell differentiation].
Płuzańska A; Małecka E; Krykowski E; Olszańska-Skorek T; Stempczyńska J; Polkowska E; Hyjek E
Pol Arch Med Wewn; 1988 Dec; 80(6):323-30. PubMed ID: 2481844
[No Abstract] [Full Text] [Related]
8. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group.
d'Amore F; Christensen BE; Brincker H; Pedersen NT; Thorling K; Hastrup J; Pedersen M; Jensen MK; Johansen P; Andersen E
Eur J Cancer; 1991; 27(10):1201-8. PubMed ID: 1835586
[TBL] [Abstract][Full Text] [Related]
9. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy].
Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347
[No Abstract] [Full Text] [Related]
10. [Lactic acidosis in non-Hodgkin's lymphoma].
Navigante AH; Chacón RD
Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
[No Abstract] [Full Text] [Related]
11. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
Pittrová H; Koza V; Vozobulová V; Cetkovský P; Skopek P; Jungerová J; Cepelák V
Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
13. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
[No Abstract] [Full Text] [Related]
14. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy and chemotherapy in stages I and II non-Hodgkin's lymphomas of Waldeyer's ring].
Hayabuchi N; Jingu K; Miyoshi M; Akasi Y; Masuda K; Komiyama S; Kikuchi M
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1428-36. PubMed ID: 2212835
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
[No Abstract] [Full Text] [Related]
19. Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
Meerwaldt JH; Carde P; Somers R; Thomas J; Kluin-Nelemans JC; Bron D; Noordijk EM; Cosset JM; Bijnens L; Teodorovic I; Hagenbeek A
Ann Oncol; 1997; 8 Suppl 1():67-70. PubMed ID: 9187434
[TBL] [Abstract][Full Text] [Related]
20. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
Pawelski S; Konopka L; Pakulska J; Gutkowska J
Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
